The Clinical Efficacy of Tolterodine Combining Ningmitai Treated for Female Overactive Bladder

Objective To observe the clinical efficacy of tolterodine combining ningmitai treatment for female overactive bladder(OAB),and try to find a way that can improve the the treatment efficacy.Methods 92 female patients with OAB were selected and randomly divided into two groups,tolterodine group and combined drug group.After 6 weeks of treatment,the two groups were compared in the average frequency of 24 h urination,the average frequency of 24 h urinary incontinence,the initial urine volume,and maximum capacity of the bladder pressure etc..Results The clinical efficacy of the combined drug group improved significantly(P0.05)compared to the tolterodine group in the above mentioned aspects.Conclusion Tolterodine combining ningmitai can improve the clinical efficacy significantly for female OAB,which should be adopted in the clinical practice.